Hepatitis C Medications
Approved Medications
- An Overview of Ribavirin (Virazol, Rebetol, Copegus) (Regularly Updated)
To read PDF, click here
From U.S. National Institutes of Health
- Both Hepatitis C Drugs Work About the Same: Study (August 11, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- ddI + Ribavirin May Cause Mitochondrial Toxicity (September 1, 2005)
In Journal of Acquired Immune Deficiency Syndromes
- An Overview of Peginterferon Alfa-2 (Pegasys, PEG-Intron) (January 10, 2005)
To read PDF, click here
From U.S. National Institutes of Health
- An Overview of Interferon Alfa-2 (Roferon-A, Intron A) (January 4, 2005)
To read PDF, click here
From U.S. National Institutes of Health
- New Hepatitis C Treatment Options Available (September 20, 2004)
Updates on generic ribavirin and the approval of two forms of peg-interferon.
To read PDF, click here
From PositiveWords
- Focus on Hepatitis: Final APRICOT, ACTG A5071 Results (September 2004)
Data indicate that sustained virologic response can be achieved with peginterferon-alfa and ribavirin in many HIV/hepatitis C-coinfected patients.
To read PDF, click here
In IAPAC Monthly, from International Association of Physicians in AIDS Care
|
|
Advertisement
|
E-Mail
Glossary
Share
